Ultragenyx
Price & Volume
Stats
See more52W Range | $29.59-$60.37 |
Market Cap | $3.2B |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $560.2M |
Revenue Growth (YoY) | 29.4% |
Gross Profit (12 Mos) | -$214.3M |
Diluted EPS | -$6.29 |
News
See moreYahoo Finance • 19 days ago
Why Ultragenyx Pharmaceutical (RARE) Is Among the Best Mid Cap Biotech Stocks to Buy
Yahoo Finance • 29 days ago
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 2 months ago
Ultragenyx to Participate at Investor Conferences in March
Yahoo Finance • 2 months ago
Ultragenyx Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Update
About
CEO | Dr. Emil D. Kakkis M.D., Ph.D. |
CFO | Mr. Howard Horn |
Address | 60 Leveroni Court, Novato, CA, United States, 94949 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 1,294 |
